0001354488-15-005616.txt : 20151222
0001354488-15-005616.hdr.sgml : 20151222
20151222142545
ACCESSION NUMBER: 0001354488-15-005616
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151217
FILED AS OF DATE: 20151222
DATE AS OF CHANGE: 20151222
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cellular Biomedicine Group, Inc.
CENTRAL INDEX KEY: 0001378624
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 861032927
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19925 STEVENS CREEK BLVD., SUITE 100
CITY: CUPERTINO
STATE: CA
ZIP: 95014
BUSINESS PHONE: (408) 973-7884
MAIL ADDRESS:
STREET 1: 19925 STEVENS CREEK BLVD., SUITE 100
CITY: CUPERTINO
STATE: CA
ZIP: 95014
FORMER COMPANY:
FORMER CONFORMED NAME: EastBridge Investment Group Corp
DATE OF NAME CHANGE: 20061019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chan Andrew K
CENTRAL INDEX KEY: 0001569877
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36498
FILM NUMBER: 151301818
MAIL ADDRESS:
STREET 1: 530 UNIVERSITY AVENUE, #17
CITY: PALO ALTO
STATE: CA
ZIP: 94301
4
1
issuerdirect_section16.xml
PRIMARY DOCUMENT
X0306
4
2015-12-17
0
0001378624
Cellular Biomedicine Group, Inc.
CBMG
0001569877
Chan Andrew K
19925 STEVENS CREEK BLVD., SUITE 100
CUPERTINO
CA
95014
1
SVP Corp Bus Dev
Common Stock
2015-12-17
4
M
0
1516
5.61
A
154461
D
Common Stock
2015-12-17
4
S
0
1516
21.28
D
152945
D
Common Stock
2015-12-18
4
S
0
10000
22.00
D
142945
D
Common Stock
2015-12-21
4
M
0
1296
3.00
A
144241
D
Common Stock
2015-12-21
4
S
0
1296
22.26
D
142945
D
Non- Qualified Stock Option (right to buy) (2013 Plan)
5.61
2015-12-17
4
M
0
1516
0
D
2023-05-16
Common Stock
1516
42452
D
Non- Qualified Stock Option (right to buy) (2011 Plan)
3.00
2015-12-21
4
M
0
1296
0
D
2023-02-20
Common Stock
1296
42759
D
The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
The option vested according to the following schedule: 1/31st per month following the vesting commencement date of May 16, 2014.
The option vested according to the following schedule: 1/36th per month following the vesting commencement date of February 20, 2013.
/s/ Andrew Chan
2015-12-22